Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 851 to 875 of about 5897

Previous 25

Website Changes

07/29/2020

An Emerging Medical Market Play with Great Opportunity

07/28/2020

Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

07/28/2020

Dianhydrogalactitol (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells

07/24/2020

FDA Grants Rare Pediatric Disease Designation to ONC201 for the Treatment of H3 K27M-Mutant Glioma

07/24/2020

Trump administration unveils four executive orders aimed at lowering drug prices

07/22/2020

GBM awareness day: Contact your legislators!

07/22/2020

First Recurrent GBM Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

07/11/2020

Comparative Epidemiology of Gliosarcoma and Glioblastoma and the Impact of Race on Overall Survival: A Systematic Literature Review

07/09/2020

Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors

07/08/2020

Musella Foundation awards another brain tumor research grants!

07/07/2020

Survival, Costs, and Health Care Resource Use by Line of Therapy in US Medicare Patients With Newly Diagnosed Glioblastoma: A Retrospective Observational Study

07/03/2020

Everolimus improves the efficacy of dasatinib in PDGFRa-driven glioma

07/03/2020

Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients

07/03/2020

Is polio the answer to curing brain tumors?

07/01/2020

Early Imaging Marker of Progressing Glioblastoma: A Window of Opportunity

06/30/2020

Musella Foundation awards two more brain tumor research grants!

06/29/2020

First annual Dragon Derby!

06/29/2020

We need your supprt for the Promising Pathway Act

06/29/2020

A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study

06/28/2020

David Zagzag, MD, Ph.D. Recognized as a Professional of the Year for 2020 by Strathmore`s Who`s Who Worldwide

06/27/2020

ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP

06/25/2020

A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas

06/24/2020

Musella Foundation Copay Program now closed to new patients

06/24/2020

New class of precision medicine strips cancer of its DNA defenses

06/24/2020

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II

Our privacy / cookie policy has changed.
Click HERE to read it!